Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01.10.2012 | Article

Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saud Arabia: a 6-year retrospective cohort study

verfasst von: H. H. Balkhy, M. S. Bawazeer, R. F. Kattan, H. M. Tamim, S. M. Al Johani, F. A. Aldughashem, H. A. Al Alem, A. Adlan, L. A. Herwaldt

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

A retrospective cohort study was conducted among hospitalized children less than 12 years of age who had Acinetobacter spp. isolated from ≥1 cultures between October 2001 and December 2007 at King Abdulaziz Medical City in Riyadh, Saudi Arabia. Children with multidrug-resistant (MDR) Acinetobacter spp. healthcare-associated infections (HAIs) were compared to children with antimicrobial-susceptible Acinetobacter spp. HAIs and to children colonized with Acinetobacter. Children with MDR Acinetobacter spp. HAIs were older (p = 0.01), more likely to be admitted to an intensive care unit (ICU) (p = 0.06), and had a higher mortality rate (p = 0.02) than colonized children. Children with MDR Acinetobacter spp. HAIs were older than children with antimicrobial-susceptible Acinetobacter spp. HAIs (p = 0.0004), but their mortality rates were similar. Among children with MDR Acinetobacter spp. HAIs, burn injuries were the most common underlying illness. HAIs caused by MDR or susceptible Acinetobacter spp. occurred after prolonged hospitalization, suggesting nosocomial acquisition. Patients infected with MDR Acinetobacter spp. frequently received inappropriate empiric therapy (73.9 %). Further studies are needed in order to identify effective strategies to prevent nosocomial transmission and effective ways of improving patient outcomes.
Literatur
1.
Zurück zum Zitat Hirai Y (1991) Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect 19(3):191–200PubMedCrossRef Hirai Y (1991) Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect 19(3):191–200PubMedCrossRef
2.
Zurück zum Zitat Hu J, Robinson JL (2010) Systematic review of invasive Acinetobacter infections in children. Can J Infect Dis Med Microbiol 21(2):83–88PubMed Hu J, Robinson JL (2010) Systematic review of invasive Acinetobacter infections in children. Can J Infect Dis Med Microbiol 21(2):83–88PubMed
3.
Zurück zum Zitat Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case–control study. Intensive Care Med 32(9):1384–1391PubMedCrossRef Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E (2006) Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case–control study. Intensive Care Med 32(9):1384–1391PubMedCrossRef
4.
Zurück zum Zitat Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8(12):751–762PubMedCrossRef Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8(12):751–762PubMedCrossRef
5.
Zurück zum Zitat Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1):97–103PubMedCrossRef Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1):97–103PubMedCrossRef
6.
Zurück zum Zitat Hsueh PR, Chen WH, Luh KT (2005) Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26(6):463–472PubMedCrossRef Hsueh PR, Chen WH, Luh KT (2005) Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26(6):463–472PubMedCrossRef
7.
Zurück zum Zitat Morgan DJ, Liang SY, Smith CL, Johnson JK, Harris AD, Furuno JP, Thom KA, Snyder GM, Day HR, Perencevich EN (2010) Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 31(7):716–721PubMedCrossRef Morgan DJ, Liang SY, Smith CL, Johnson JK, Harris AD, Furuno JP, Thom KA, Snyder GM, Day HR, Perencevich EN (2010) Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 31(7):716–721PubMedCrossRef
8.
Zurück zum Zitat Corbella X, Pujol M, Ayats J, Sendra M, Ardanuy C, Domínguez MA, Liñares J, Ariza J, Gudiol F (1996) Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 23(2):329–334PubMedCrossRef Corbella X, Pujol M, Ayats J, Sendra M, Ardanuy C, Domínguez MA, Liñares J, Ariza J, Gudiol F (1996) Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 23(2):329–334PubMedCrossRef
9.
Zurück zum Zitat Ayats J, Corbella X, Ardanuy C, Domínguez MA, Ricart A, Ariza J, Martin R, Liñares J (1997) Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 37(4):287–295PubMedCrossRef Ayats J, Corbella X, Ardanuy C, Domínguez MA, Ricart A, Ariza J, Martin R, Liñares J (1997) Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 37(4):287–295PubMedCrossRef
10.
Zurück zum Zitat Thom KA, Hsiao WW, Harris AD, Stine OC, Rasko DA, Johnson JK (2010) Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains. Am J Infect Control 38(9):751–753PubMedCrossRef Thom KA, Hsiao WW, Harris AD, Stine OC, Rasko DA, Johnson JK (2010) Patients with Acinetobacter baumannii bloodstream infections are colonized in the gastrointestinal tract with identical strains. Am J Infect Control 38(9):751–753PubMedCrossRef
11.
Zurück zum Zitat Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332PubMedCrossRef Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332PubMedCrossRef
12.
Zurück zum Zitat SAS Release 9.1. (2002) SAS Institute Inc., Cary, NC, USA SAS Release 9.1. (2002) SAS Institute Inc., Cary, NC, USA
13.
Zurück zum Zitat Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y (2004) Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 10(6):1125–1128PubMedCrossRef Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y (2004) Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 10(6):1125–1128PubMedCrossRef
14.
Zurück zum Zitat Bilavsky E, Schwaber MJ, Carmeli Y (2010) How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies. Curr Opin Infect Dis 23(4):327–331PubMedCrossRef Bilavsky E, Schwaber MJ, Carmeli Y (2010) How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies. Curr Opin Infect Dis 23(4):327–331PubMedCrossRef
15.
Zurück zum Zitat Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D, Zlotkin A, Smollan G, Rahav G (2010) Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31(6):620–626PubMedCrossRef Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D, Zlotkin A, Smollan G, Rahav G (2010) Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31(6):620–626PubMedCrossRef
16.
Zurück zum Zitat Dealler S (1998) Nosocomial outbreak of multi-resistant Acinetobacter sp. on an intensive care unit: possible association with ventilation equipment. J Hosp Infect 38(2):147–148PubMedCrossRef Dealler S (1998) Nosocomial outbreak of multi-resistant Acinetobacter sp. on an intensive care unit: possible association with ventilation equipment. J Hosp Infect 38(2):147–148PubMedCrossRef
17.
Zurück zum Zitat Catalano M, Quelle LS, Jeric PE, Di Martino A, Maimone SM (1999) Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect 42(1):27–35PubMedCrossRef Catalano M, Quelle LS, Jeric PE, Di Martino A, Maimone SM (1999) Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect 42(1):27–35PubMedCrossRef
18.
Zurück zum Zitat Michalopoulos A, Falagas ME (2010) Treatment of Acinetobacter infections. Expert Opin Pharmacother 11(5):779–788PubMedCrossRef Michalopoulos A, Falagas ME (2010) Treatment of Acinetobacter infections. Expert Opin Pharmacother 11(5):779–788PubMedCrossRef
19.
Zurück zum Zitat Falagas ME, Kasiakou SK, Rafailidis PI, Zouglakis G, Morfou P (2006) Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 57(6):1251–1254PubMedCrossRef Falagas ME, Kasiakou SK, Rafailidis PI, Zouglakis G, Morfou P (2006) Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J Antimicrob Chemother 57(6):1251–1254PubMedCrossRef
Metadaten
Titel
Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saud Arabia: a 6-year retrospective cohort study
verfasst von
H. H. Balkhy
M. S. Bawazeer
R. F. Kattan
H. M. Tamim
S. M. Al Johani
F. A. Aldughashem
H. A. Al Alem
A. Adlan
L. A. Herwaldt
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1608-8

Weitere Artikel der Ausgabe 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.